Real-world Secukinumab Outcomes in Canadian HS Patients

Clinical trial NCT07282015 · RECRUITING

Trial details

NCT number: NCT07282015
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Hidradenitis Suppurativa

Start date: 2025-12-12
Primary completion: 2028-02-11
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.